Mr. Dolan is Chairman of the Board of Trustees of Tufts University. He was elected Chair in 2013, having served on the Tufts Board since 2001. He is Chairman of the Board elect of the Partnership for A Healthier America and has served on that Board since 2010. He is also currently on the Board of Amplitude Health Care.
Previously, from 1988-2006, Mr. Dolan was at Bristol-Myers Squibb, eventually serving as Chairman and CEO, and as CEO. He joined Bristol-Myers Squibb from General Foods. After more than a decade leading the company’s Consumer Products, Nutritionals, and Medical Device businesses, he was named CEO in 2001 at age 45. As CEO, he led the acquisition of DuPont Pharmaceuticals, which brought Eliquis to the company, and by 2019, Eliquis was the second largest drug in global industry annual prescription drug revenue. In 2001, the successful investment in Imclone’s Erbitux successfully bolstered Bristol-Myers Squibb’s oncology business until the introductions of blockbusters Sprycel and Yervoy. Ushering the company into biologics, in 2004 Mr. Dolan licensed the immuno-oncology compound that became Yervoy, named the Biotech Discovery of the Decade in 2016 for extending survival in some of the hardest to treat forms of cancer. In 2006, he strengthened the company’s commitment to biologics with the largest capital investment in the company’s history to build the first Bristol-Myers Squibb biologics manufacturing facility.
Post Bristol-Myers Squibb, he has served as Chairman and CEO of GeminX, a venture capital backed startup oncology company that was successfully sold to Cephalon Pharmaceuticals for $225 million.
More recently, from 2014-2019, he was Chairman of Allied Minds, an innovation company that forms, funds, manages and builds startups based on early-stage technology.
Throughout his career, Mr. Dolan has served on the boards of multiple for-profits and not-for-profits, including the American Express Company, ChildObesity180 (as Chairman) and the Tuck School Board of Overseers.
Mr. Dolan graduated magna cum laude from Tufts University in 1978 with a Bachelor of Arts degree. He then earned an MBA from the Tuck School of Business at Dartmouth College in 1980.